What is Janux Therapeutics's investing cash flow?

Janux Therapeutics (JANX) reported investing cash flow of $8.29M in Q1 2026.

How has Janux Therapeutics's investing cash flow changed year-over-year?

Janux Therapeutics's investing cash flow increased by 102.4% year-over-year, from -$340.39M to $8.29M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Janux Therapeutics JANX Investing Cash Flow

Investing Cash Flow at other companies

Johnson & JohnsonJNJ

-$1.04B-250%

AmgenAMGN

-$716M-60.2%

Regeneron PharmaceuticalsREGN

-$428.9M-166%

XencorXNCR

$26.68M+95.2%

AbbVieABBV

-$574M+21.9%

Vor BiopharmaVOR

-$263.24M-114,351%

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.1%

Enterprise value$862.55M-35.9%

P/S65×-84.6×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's investing cash flow?: Janux Therapeutics (JANX) reported investing cash flow of $8.29M in Q1 2026.
How has Janux Therapeutics's investing cash flow changed year-over-year?: Janux Therapeutics's investing cash flow increased by 102.4% year-over-year, from -$340.39M to $8.29M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.